本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Arcutis Biotherapeutics Inc.

20.91
-0.7200-3.33%
盤後21.320.4100+1.96%19:57 EDT
成交量:161.87萬
成交額:3,397.70萬
市值:25.07億
市盈率:-28.15
高:21.84
開:21.75
低:20.34
收:21.63
52周最高:21.84
52周最低:8.03
股本:1.20億
流通股本:8,558.07萬
量比:0.95
換手率:1.89%
股息:- -
股息率:- -
每股收益(TTM):-0.7427
每股收益(LYR):-1.1578
淨資產收益率:-57.33%
總資產收益率:-13.46%
市淨率:18.04
市盈率(LYR):-18.06

資料載入中...

2025/07/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/07/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/07/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/17

重要事件披露

Form 8-K - Current report
2025/05/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/06

重要事件披露

Form 8-K - Current report
2025/05/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/04/10

重要事件披露

Form 8-K - Current report
2025/04/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/04/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities